Department of Medicine

Since its inception, the Health Services Foundation General Endowment Fund (HSF-GEF) has played a pivotal role in advancing UAB’s mission of excellence in research, clinical care, and medical education. Established to support institutional initiatives that often fall outside traditional funding mechanisms, the HSF-GEF has become a cornerstone for building cutting-edge capacities within the academic health center. The program empowers faculty innovation, fosters interdisciplinary collaboration, and ensures UAB remains at the forefront of medical advancement.

Kirk Habegger, Ph.D., Professor of Medicine in the UAB Department of Medicine Division of Endocrinology, Diabetes and Metabolism, has received funding from Eli Lilly and Company to continue investigation of glucagon receptor activation in incretin-based obesity therapies.

Julius E. Linn Jr., M.D., who died Aug. 4, 2025, at age 84, devoted five decades of his professional life to advancing medical communication and preserving Alabama’s cultural heritage. His death marks the end of a remarkable career at The University of Alabama at Birmingham (UAB) that bridged the worlds of scientific research, medical publishing, and historical preservation.

With the growth of clinical research and trials at the University of Alabama at Birmingham (UAB) and to meet the evolving needs of investigators and study teams, two longstanding support programs—the UAB Department of Medicine’s Clinical Research Enterprise (CRE) and the Center for Clinical and Translational Science (CCTS) Clinical Research Support Program (CRSP)—have merged to form the Clinical Research Support Enterprise (CReSt).

Joseph Johnson, M.D., associate professor in the Department of Orthopaedic Surgery at the University of Alabama at Birmingham (UAB), has been awarded a Pilot and Feasibility Study grant from the UAB Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center (CAMBAC). His study, titled “Immunologic Phenotyping of Fracture-Related Infection Patients at Risk for Treatment Failure,” seeks to improve clinical outcomes for patients with fracture-related infections (FRIs) through early immunologic intervention.

Amy Warriner, M.D., professor in the Department of Medicine, has been named the 2025 recipient of the Brewer-Heslin Award for Professionalism in Medicine.

After six years of pain, fatigue, and unanswered questions, Army veteran Jason Hall finally found hope through UAB’s Undiagnosed Diseases Program, which identified his condition and provided life-changing treatment within days. Today, Hall has regained his strength, mobility, and independence—and encourages others to keep searching for answers.

Bassel El-Rayes, M.D., professor in the division of Hematology and Oncology, has been named the latest recipient of the school’s Featured Discovery Award. This recognition celebrates significant research contributions made by faculty and highlights the impact of their scientific advancements.

A new study led by UAB Comprehensive Diabetes Center Associate Scientist Fernando Bril, M.D., provides the first evidence that MASLD prevalence is beginning to decrease in adults with diabetes in the U.S. for the first time in decades. However, this good news is overshadowed by the significant increase observed in liver fibrosis.

A recent study authored by UAB researchers in the departments of Neurology, Medicine, and Epidemiology analyzed a decade of data to reveal that lack of access to stroke-related clinical trials may limit access to innovative treatments in geographic regions with high stroke burdens. Stroke is a leading cause of death and disability, affecting more than 795,000 people annually, with age-adjusted mortality rates varying widely by state.

After a national search, Mark Dransfield, M.D., has been appointed chair of the UAB Department of Medicine, effective Sept. 1, 2025.

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is. Mycoplasmas are the smallest free-living organisms. They can cause drug-resistant bacterial infections that target various parts of the body, including respiratory and urinary systems and genitalia. Mycoplasmas commonly cause lung infections and often require a special antibiotic to treat the bacterium. Most antibiotics weaken bacteria by penetrating their cell walls. Mycoplasmas, however, don’t have cell walls to weaken.

Academic medical centers (AMCs) are among the United States’ most active hives of biomedical innovation thanks to their often robust research enterprises. Increasingly, AMCs like the Heersink School of Medicine play a central role in another realm of innovation: the biomedical/biotech start-up space.

Meet some of Heersink’s outstanding new faculty members. Each issue, we introduce you to several of the exceptional new faculty that have joined the Heersink School of Medicine. These outstanding recruits—just a few of the many new faces we welcome to our faculty each year—bring with them a wealth of expertise, impressive research portfolios, and a commitment to excellence in shaping the future of medicine and health care.

The UAB Medicine Institute for Leadership, the flagship program of the UAB Medicine Leadership Development Office, recently celebrated the graduation of its 10th cohort.

The University of Alabama at Birmingham startup TIXiMED, Inc., has successfully completed a Phase 1 single ascending dose study of the drug TIX100 in humans, marking a key milestone in the development of a first-of-its kind oral therapy for Type 1 diabetes (T1D).

Chronic illnesses don’t take Saturdays off, and neither does the team at the UAB O’Neal Comprehensive Cancer Center Infusion Clinic. After experiencing a staggering 44 percent increase in patient encounters since 2020, this 84-bay infusion clinic turned to a dedicated team of multidisciplinary clinicians to pioneer Saturday infusion services. This highly trained team is ensuring that patients with cancer and other chronic diseases have access to critical treatments like chemotherapy and immunotherapy on the weekends, keeping them in the hands of trusted specialists and out of emergency rooms.

Twelve UAB employees recently graduated from the Emerging Leaders Series (ELS) spring 2025 leadership development program. The program, presented by the UAB Medicine Leadership Development Office (LDO), recognized its third cohort of graduates at a ceremony on June 5.

Ananda Basu, MBBS, MD, FRCP, M.D., has been appointed as an associate director of the UAB Comprehensive Diabetes Center (UCDC) and will play an integral role on the center’s leadership team.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing tools for further exploration into pancreatic alpha cell function in both Type 1 and 2 diabetes and other metabolic disorders.

The UAB Pancreatobiliary Disease Center (PDC) hosted the second annual Hops & Hope Fair on Saturday, May 31, 2025 at Cahaba Brewing Company.

The UAB O’Neal Comprehensive Cancer Center recently announced five winners of the O’Neal Invests grant awards, two generously funded by the Breast Cancer Research Foundation of Alabama (BCRFA).

UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.

Infectious Diseases faculty Bobbie Van Der Pol, Ph.D., MPH, and Olivia Van Gerwen, M.D., MPH, were recognized by the American Sexually Transmitted Diseases Association for their outstanding contributions to the field.

The UAB Marnix E. Heersink School of Medicine recognized 15 faculty members for their outstanding contributions to research, education, and clinical care at the Spring 2025 Endowed Chairs and Professorships Reception.

The UAB Heersink School of Medicine is proud to announce the recipients of the 2024/2025 Multi-PI Awards, each funded with $150,000 per year for two years. These awards recognize outstanding collaborative research efforts aimed at addressing critical health challenges.

The UAB Heersink School of Medicine is proud to announce the 19 winners of the 2025 Dean's Excellence Awards for Faculty.

The UAB Medicine Leadership Development Office recently recognized eight individuals in its sixth cohort of Sharing Authentically to Inspire and Lead (SAIL). The spring 2025 graduates were honored at a ceremony on April 8.

The American College of Cardiology (ACC), in partnership with the American Association of Cardiologists of Indian Origin, has named Navin Nanda, M.D., distinguished professor of Medicine and Cardiovascular Disease, as the new ACC International Service Award namesake.

Gregory Payne, M.D., Ph.D., associate professor of Medicine, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

The National Institute of Diabetes and Digestive and Kidney Diseases reports that chronic kidney disease affects more than one in seven adults in the United States, an estimated 35.5 million Americans. Additionally, the risk of developing kidney disease increases with conditions such as diabetes or high blood pressure.

A new study by Rita Basu, M.D., and collaborators, finds that restoring hepatic glycogen improves nocturnal glucose regulation in humans with Type 2 diabetes.

Timmy Lee, M.D., MSPH, will serve as the next division director for the UAB Division of Nephrology, effective July 1, 2025.

As NTM cases rise, the UAB Nontuberculous Mycobacterial (NTM) Program, led by Bryan Garcia, M.D., in partnership with German Henostroza, M.D., has formed a multidisciplinary team to provide individualized care, improve diagnosis, and enhance treatment outcomes for patients with NTM.

Rebekah Weil, M.D., has been named the associate division director for medical education for the Division of General Internal Medicine and Population Science.

Rui Lu, Ph.D., associate professor in the Department of Medicine, has been named the latest recipient of the school's Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

Sandeep Bodduluri, Ph.D., is working to use artificial intelligence (AI) to improve health care processes and the patient experience. Through courses offered by the Marnix E. Heersink Institute for Biomedical Innovation, he is sharing his knowledge with clinicians at UAB and abroad, emphasizing the importance of interaction between clinicians and engineers in AI research and development.

Dana Rizk, M.D., has been appointed associate dean for Clinical Trials and Cynthia Joiner, Ph.D., MPH, R.N., has been named assistant dean for Clinical Research Operations in the Heersink School of Medicine, effective March 1, 2025. Both of these newly created roles will work closely with Senior Associate Dean for Clinical and Translational Research, Orlando Gutiérrez, M.D., to lead the Heersink School of Medicine’s efforts to advance clinical trials.

Just weeks after discharge, the patient is back at the hospital. This time, the infection has worsened, sepsis has set in, and emergency surgery is needed. A preventable outcome had intervention come sooner.

Martina Gonzalez-Gomez, M.D., M.Sc., program manager for the Global Neurosurgery program in the Department of Neurosurgery, and James Johnston, M.D., professor in the Department of Neurosurgery and director of the Pediatric Neurosurgery division, co-instruct the Global Surgery course. In 2023, we met with Gonzalez-Gomez and Johnston to learn more about their vision for the course, which launched with the introduction of the UAB Master of Science in Global Health (MSGH) program offered by the UAB Heersink School of Medicine and the UAB School of Public Health (SOPH).

UAB Medicine’s Leadership Development Office welcomed 16 individuals in its 10th cohort of Institute for Leadership in January 2025. UAB Medicine Institute for Leadership is a flagship program of the Leadership Development Office, aimed at empowering leaders across UAB and the UAB Health System. It features an initial DISC assessment and a robust agenda of guest speakers from executive-level leadership positions at UAB, including Institute alumni, throughout the program.

The UAB Heersink School of Medicine is proud to announce the 2025 Pittman Scholars. This prestigious honor recognizes assistant professors who have held that rank for fewer than five years for their exceptional research achievements and potential for future contributions to their fields. Named after former School of Medicine Dean James A. Pittman Jr., M.D., this award highlights the school's commitment to fostering innovation and excellence in medical research.

November 2024 marked 20 years since the establishment of the Evelyn F. McKnight Brain Institute (EMBI) at UAB. The institute was made possible by a generous gift from the McKnight Brain Research Foundation (MBRF), matched by the university, to support research in cognitive aging and age-related memory loss. Ronald Lazar, Ph.D., professor in the UAB Department of Neurology, has been director of the institute since 2017.

Twenty-two UAB leaders graduated among the ninth cohort of the UAB Medicine Institute for Leadership on Dec. 11, 2024. Institute for Leadership is a flagship program of the UAB Medicine Leadership Development Office, an organization dedicated to providing tools and training to empower UAB Medicine’s leaders and the individuals and groups they manage.

Nita Limdi, PharmD, Ph.D., MSPH, FAHA, has been appointed associate dean for Genomic Medicine, effective Oct. 1. Limdi will lead efforts to expand UAB's Genomic Medicine program, focusing on interdisciplinary collaborations, securing grant funding, and enhancing partnerships. Her extensive research in pharmacogenomics and leadership in national consortia underscore her commitment to advancing genomic medicine.

The AI in Medicine and Nursing Symposium, hosted by the UAB Heersink School of Medicine, UAB Medicine, UAB School of Health Professions, UAB School of Nursing, and Maastricht University Faculty of Science and Engineering, concluded successfully, bringing together leading experts, researchers, and industry representatives to explore the transformative potential of artificial intelligence (AI) in health care.

Twenty-two UAB employees recently graduated from the Emerging Leaders Series (ELS) fall 2024 leadership development program. The program, presented by UAB Medicine’s Leadership Development Office (LDO), recognized its second cohort of graduates at a ceremony on Nov. 7.

The UAB Department of Microbiology and the Center for AIDS Research (CFAR) hosted the inaugural HIV Basic and Translational Research Symposium Wednesday, Oct. 23, 2024, at the UAB Hilton Hotel. The all-day event featured speakers from the university and Southern Research, time for discussion, and a poster session.  

For over 20 years, Lisa Willett, M.D., MACM, has shaped the medical education landscape through dedication, mentorship, and advocacy for her trainees. She received the 2024 Ellen Gregg Ingalls/UAB National Alumni Society Lifetime Achievement in Teaching Award in recognition of her contributions at UAB and beyond, influencing future physicians and fostering a culture of excellence without ego, the motto she coined to describe UAB internal medicine residents.

The University of Alabama at Birmingham’s (UAB) Harbert Institute for Innovation and Entrepreneurship (HIIE) celebrated its annual Innovation Awards on October 11, 2024, recognizing outstanding innovators and entrepreneurial achievements. Anath Shalev, M.D., director of the UAB Comprehensive Diabetes Center and founder of TIXiMED, was awarded the 2024 Excellence in Entrepreneurship Award, the institute’s highest honor. Shalev's start-up, TIXiMED, recently advanced toward clinical trials after receiving FDA clearance for its novel Type 1 diabetes treatment, TIX100.